In a conversation with Pharmaceutical Executive, Morten Graugaard, CEO, Orbis Medicines, discussed FDA’s approval of Icotyde ...
The firm will deliver SGT-212 to patients' brains and intravenously to try to restore frataxin levels and diminish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results